Omega-3 supplements are often viewed as an easy way to enhance brain health, particularly as we age. However, recent research casts doubt on this assumption, revealing complexities in how these supplements interact with cognitive functions over time.
The Complexity of Omega-3 Supplements and Brain Aging
Millions of people incorporate omega-3 supplements, such as fish oil, krill oil, and flaxseed oil, into their daily routines to promote heart, joint, eye, and brain health. This trend is particularly prevalent among older adults who aim to maintain mental sharpness. However, a new study suggests that the connection between omega-3 supplementation and brain aging may be more complicated than previously thought.
Researchers in China conducted an analysis utilizing data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a long-term project tracking aging, memory, brain scans, genetics, and Alzheimer’s disease. The aim was to explore whether omega-3 supplementation correlates with changes in cognition and Alzheimer’s-related brain biology over time.
The findings were surprising. Participants who used omega-3 supplements exhibited a more rapid cognitive decline compared to nonusers across three established measures: the Mini-Mental State Examination (MMSE), the Alzheimer’s Disease Assessment Scale Cognitive Subscale 13 (ADAS-Cog13), and the Clinical Dementia Rating Sum of Boxes (CDR-SB).
“In contrast to the common assumption of a neuroprotective effect, omega-3 supplementation was linked to accelerated cognitive decline,” the researchers noted.
Research Design and Participant Analysis
This study initially included 1,814 older adults from the ADNI cohort. After matching omega-3 users with comparable nonusers based on age, sex, APOE ε4 status, and diagnosis, the final analysis focused on 273 supplement consumers and 546 nonusers. Participants were monitored over a median follow-up period of five years, with variations in cognitive status ranging from normal aging to mild cognitive impairment and Alzheimer’s disease.
The majority of reported omega-3 consumption was attributed to fish oil supplements, with some participants also using flaxseed oil and krill oil.
Results indicated that omega-3 use was linked to a quicker decline in MMSE scores, along with accelerated deterioration in ADAS-Cog13 and CDR-SB assessments. Although the additional decline was less than the typical yearly progress observed in Alzheimer’s disease, it remained statistically significant across multiple measures.
Brain Imaging Insights
Among the study’s most compelling findings was the brain imaging data. The accelerated cognitive decline associated with omega-3 use was not explained by conventional Alzheimer’s disease markers such as amyloid plaques, tau accumulation, or gray matter loss.
Instead, the key indicator appeared to be diminished glucose metabolism in brain regions susceptible to Alzheimer’s. This was determined through FDG PET scans, which provide insights into the functionality of brain cells and their connections.
Significantly, diminished glucose metabolism accounted for a portion of the connection between omega-3 use and cognitive decline, explaining 30.8% of the effect on MMSE degradation, 40.8% on ADAS-Cog13 decline, and 19% on CDR-SB worsening.
“These findings emphasize the need for a more nuanced understanding of omega-3’s role in the aging human brain,” the authors concluded.
Future Research Directions
This study does not definitively establish that omega-3 supplements induce cognitive decline. Due to its observational nature, other variables could have influenced the outcomes. The researchers also could not closely monitor specific dosages, long-term adherence, quality of supplements, or whether certain fish oil products had oxidized. Additionally, the participant demographic was predominantly White and highly educated, which may limit the generalizability of the results.
Nonetheless, the findings serve as an important reminder that omega-3 supplements should not be automatically regarded as a foolproof strategy for maintaining brain health, especially for older adults concerned about memory issues.
The authors stress that further research is necessary to ascertain who might derive benefits from omega-3 supplements, who may not, and whether issues like dosage, supplement type, APOE ε4 status, baseline omega-3 levels, or existing brain changes contribute to varying effects. Until more is known, individuals considering omega-3 supplementation for cognitive preservation should consult a healthcare professional rather than assuming that higher intake guarantees better outcomes.
Reference: “The association between omega-3 supplementation and cognitive decline in older adults” by Zheng-Bin Liao, Zi-Cheng Hu, Gui-Hua Zeng, Jia Chen, Xin-Peng Li, Yu-Hui Liu, Xiu-Qing Yao and Ye-Ran Wang, 17 April 2026, The Journal of Prevention of Alzheimer’s Disease.
DOI: 10.1016/j.tjpad.2026.100569
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.
